Cancer Family
Mediastinal Neoplasm
CI-CAN-00000259Explore in graph →
Non-malignant69 active trials1 approved drugs
Loading cancer entity…
Cancer Family
CI-CAN-00000259Explore in graph →
Clinical trials
162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04358458 | First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas | terminated | Phase 1 / Phase 2 | 46 | GenmabINDUSTRY | 5 | Oct 24, 2024 | clinicaltrials |
| NCT02499952 | Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors | terminated | Phase 2 | 12 | Nasser Hanna, M.D.OTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT00315211 |
| Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer |
| terminated |
| Phase 2 |
| 7 |
| Aultman Health FoundationOTHER |
| 1 |
| Aug 20, 2018 |
| clinicaltrials |
Data updated 22 days agoSource updated Oct 24, 2024source: clinicaltrials